171 related articles for article (PubMed ID: 23664694)
1. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas.
Locatelli M; Ferrero S; Martinelli Boneschi F; Boiocchi L; Zavanone M; Maria Gaini S; Bello L; Valentino S; Barbati E; Nebuloni M; Mantovani A; Garlanda C
J Neuroimmunol; 2013 Jul; 260(1-2):99-106. PubMed ID: 23664694
[TBL] [Abstract][Full Text] [Related]
2. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers.
Prosniak M; Harshyne LA; Andrews DW; Kenyon LC; Bedelbaeva K; Apanasovich TV; Heber-Katz E; Curtis MT; Cotzia P; Hooper DC
Clin Cancer Res; 2013 Jul; 19(14):3776-86. PubMed ID: 23741072
[TBL] [Abstract][Full Text] [Related]
3. PTX3 acts as an extrinsic oncosuppressor.
Bonavita E; Mantovani A; Garlanda C
Oncotarget; 2015 Oct; 6(32):32309-10. PubMed ID: 26457877
[No Abstract] [Full Text] [Related]
4. Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis.
Wesley UV; Sutton I; Clark PA; Cunningham K; Larrain C; Kuo JS; Dempsey RJ
Brain Res; 2022 Feb; 1776():147752. PubMed ID: 34906547
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo.
Tung JN; Ko CP; Yang SF; Cheng CW; Chen PN; Chang CY; Lin CL; Yang TF; Hsieh YH; Chen KC
J Neurooncol; 2016 Sep; 129(2):201-9. PubMed ID: 27278519
[TBL] [Abstract][Full Text] [Related]
6. The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling.
Inforzato A; Jaillon S; Moalli F; Barbati E; Bonavita E; Bottazzi B; Mantovani A; Garlanda C
Tissue Antigens; 2011 Apr; 77(4):271-82. PubMed ID: 21388349
[TBL] [Abstract][Full Text] [Related]
7. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.
Mantovani A; Valentino S; Gentile S; Inforzato A; Bottazzi B; Garlanda C
Ann N Y Acad Sci; 2013 May; 1285():1-14. PubMed ID: 23527487
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity.
Lin Q; Fu F; Shen L; Zhu B
Heart Lung; 2013; 42(2):139-45. PubMed ID: 23273657
[TBL] [Abstract][Full Text] [Related]
10. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases.
Jaillon S; Bonavita E; Gentile S; Rubino M; Laface I; Garlanda C; Mantovani A
Int Arch Allergy Immunol; 2014; 165(3):165-78. PubMed ID: 25531094
[TBL] [Abstract][Full Text] [Related]
11. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
12. The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility.
Bottazzi B; Bastone A; Doni A; Garlanda C; Valentino S; Deban L; Maina V; Cotena A; Moalli F; Vago L; Salustri A; Romani L; Mantovani A
J Leukoc Biol; 2006 May; 79(5):909-12. PubMed ID: 16478917
[TBL] [Abstract][Full Text] [Related]
13. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications.
Cieślik P; Hrycek A
Autoimmunity; 2012 Mar; 45(2):119-28. PubMed ID: 21988562
[TBL] [Abstract][Full Text] [Related]
14. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
[TBL] [Abstract][Full Text] [Related]
15. Low expression of pentraxin 3 and nuclear factor-like 2 implying a relatively longer overall survival time in gliomas.
Ke HH; Hueng DY; Tsai WC
Chin J Physiol; 2019; 62(1):35-43. PubMed ID: 30942197
[TBL] [Abstract][Full Text] [Related]
16. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
Norata GD; Garlanda C; Catapano AL
Trends Cardiovasc Med; 2010 Feb; 20(2):35-40. PubMed ID: 20656213
[TBL] [Abstract][Full Text] [Related]
17. Pentraxin-3 expression in acute renal allograft rejection.
Imai N; Nishi S; Yoshita K; Ito Y; Osawa Y; Takahashi K; Nakagawa Y; Saito K; Takahashi K; Narita I
Clin Transplant; 2012 Jul; 26 Suppl 24():25-31. PubMed ID: 22747472
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
19. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility.
Garlanda C; Bottazzi B; Bastone A; Mantovani A
Annu Rev Immunol; 2005; 23():337-66. PubMed ID: 15771574
[TBL] [Abstract][Full Text] [Related]
20. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity.
Bottazzi B; Garlanda C; Cotena A; Moalli F; Jaillon S; Deban L; Mantovani A
Immunol Rev; 2009 Jan; 227(1):9-18. PubMed ID: 19120471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
